Decreased Dupilumab Dosing Frequency Maintains Long-Term Response in Patients With Eosinophilic Esophagitis
Clinical Gastroenterology and Hepatology · 2026-04
DOI: 10.1016/j.cgh.2026.03.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-04. Verfasst von Christopher J Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
- Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Division of Gastroenterology and Hepatology, Department of Medicine, C…
Zitieren
APA
Lee, C. J., Sperling, G. L., Hendrick, G. N., & Dellon, E. S. (2026). Decreased Dupilumab Dosing Frequency Maintains Long-Term Response in Patients With Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.03.025
Vancouver
Lee CJ, Sperling GL, Hendrick GN, Dellon ES. Decreased Dupilumab Dosing Frequency Maintains Long-Term Response in Patients With Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.03.025
BibTeX
@article{Lee2026,
author = {Lee, Christopher J and Sperling, Gabriel L and Hendrick, Gustaf N and Dellon, Evan S},
title = {Decreased Dupilumab Dosing Frequency Maintains Long-Term Response in Patients With Eosinophilic Esophagitis},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.03.025}
}
EUVIMED